Childhood obesity: Immune response and nutritional approaches

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Magrone, Thea ^a   Jirillo, Emilio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Atherosclerosis; Children; Diabetes; Immunity; Microbiota; Nutrition; Obesity; Oxidative stress

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; MELATONIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POLYPHENOL; POLYUNSATURATED FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; VITAMIN D;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; BODY MASS; CELL INFILTRATION; CHILDHOOD OBESITY; DIETARY INTAKE; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; LIFESTYLE; NONHUMAN; NUTRITION; OXIDATIVE STRESS; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 84926612652     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00076     Document Type: Review

References (200)

1. International Association for the Study of Obesity. Obesity the Global Epidemic (2013). Available from: http://www.iaso.org/iotg/obesitytheglobalepidemic
2. Nicklas TA, Baranowski T, Cullen KW, Berenson G. Eating patterns, dietary quality and obesity. J Am Coll Nutr (2001) 20:599-608. doi: 10.1080/07315724.2001.10719064
3. Parsons TJ, Power C, Logan S, Summerbell CD. Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord (1999) 23:S1-107.
4. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med (1997) 337:869-73. doi:10.1056/NEJM199709253371301
5. Lobstein T, Baur L, Uauy R; IASO International Obesity TaskForce. Obesity in children and young people: a crisis in public health. Obes Rev (2004) 5:4-104. doi:10.1111/j.1467-789X.2004.00133.x
6. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord (2004) 28:S2-9. doi:10.1038/sj.ijo.0802804
7. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes (2006) 1:11-25. doi:10.1080/17477160600586747
8. Monteiro CA, Conde WL, Lu B, Popkin BM. Obesity and inequities in health in the developing world. Int J Obes Relat Metab Disord (2004) 28:1181-6. doi:10.1038/sj.ijo.0802716
9. Aguilera CM, Olza J, Gil A. Genetic susceptibility to obesity and metabolic syndrome in childhood. Nutr Hosp (2013) 28:44-55. doi:10.3305/nh.2013.28.sup5.6917
10. Serra Majem L, Ribas Barba L, Aranceta Bartrina J, Pérez Rodrigo C, Saavedra Santana P, Peña Quintana L. [Childhood and adolescent obesity in Spain. Results of the enKid study (1998-2000)]. Med Clin (Barc) (2003) 121:725-32. doi:10.1016/S0025-7753(03)74077-9
11. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med (1995) 333:1165-70. doi:10.1056/NEJM199511023331801
12. Bautista-Castaño I, Sangil-Monroy M, Serra-Majem L; Comité de Nutrición y Obesidad Infantil de la Sociedad Española de Nutrición Comunitaria. [Knowledge and gaps on the role of nutrition and physical activity on the onset of childhood obesity]. Med Clin (Barc) (2004) 123:782-93.
13. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord (2004) 28:159-66. doi:10.1038/sj.ijo.0802515
14. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics (1988) 82:309-18.
15. Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics (2012) 129:557-70. doi:10.1542/peds.2011-2912
16. Shu CJ, Benoist C, Mathis D. The immune system's involvement in obesity-driven type 2 diabetes. Semin Immunol (2012) 24:436-42. doi:10.1016/j.smim.2012.12.001
17. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis (2006) 6:438-46. doi:10.1016/S1473-3099(06)70523-0
18. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc (2012) 71:298-306. doi:10.1017/S0029665112000158
19. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 29:415-45. doi:10.1146/annurev-immunol-031210-101322
20. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 259:87-91. doi:10.1126/science.7678183
21. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 286:327-34. doi:10.1001/jama.286.3.327
22. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 117:175-84. doi:10.1172/JCI29881
23. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes (2007) 56:16-23. doi:10.2337/db06-1076
24. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 18:363-74. doi:10.1038/nm.2627
25. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 72:219-46. doi:10.1146/annurev-physiol-021909-135846
26. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 8:301-9. doi:10.1016/j.cmet.2008.08.015
27. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest (2005) 115:1111-9. doi:10.1172/JCI25102
28. Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells (2014) 37:365-71. doi:10.14348/molcells.2014.0074
29. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 103:467-76. doi:10.1161/CIRCRESAHA.108.177105
30. O'Rourke RW, White AE, Metcalf MD, Winters BR, Diggs BS, Zhu X. Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. Metabolism (2012) 61:1152-61. doi:10.1016/j.metabol.2012.01.018
31. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA (2013) 110:5133-8. doi:10.1073/pnas.1215840110
32. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 15:930-9. doi:10.1038/nm.2002
33. Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol (2014) 192:623-9. doi:10.4049/jimmunol.1302181
34. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D. Obesity predisposes to Th17 bias. Eur J Immunol (2009) 39:2629-35. doi:10.1002/eji.200838893
35. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) (2009) 33:151-6. doi:10.1038/ijo.2008.216
36. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2011) 186:1162-72. doi:10.4049/jimmunol.1002615
37. Zúñiga LA, Shen WJ, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol (2010) 185:6947-59. doi:10.4049/jimmunol.1001269
38. Pini M, Fantuzzi G. Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J Leukoc Biol (2010) 87:51-8. doi:10.1189/jlb.0309188
39. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev (2010) 21:449-53. doi:10.1016/j.cytogfr.2010.10.005
40. Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, et al. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis. J Immunol (2014) 193:4344-55. doi:10.4049/jimmunol.1400181
41. Rausch ME, Weisberg S, Vardhana P, Tortoriello DV. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) (2008) 32:451-63. doi:10.1038/sj.ijo.0803744
42. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 15:914-20. doi:10.1038/nm.1964
43. Jiang E, Perrard XD, Yang D, Khan IM, Perrard JL, Smith CW, et al. Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue. Arterioscler Thromb Vasc Biol (2014) 34:34-43. doi:10.1161/ATVBAHA.113.302077
44. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 17:610-7. doi:10.1038/nm.2353
45. Abeysekara P, Turchi R, O'Neil M. Obesity and children with special healthcare needs: special considerations for a special population. Curr Opin Pediatr (2014) 26:508-15. doi:10.1097/MOP.0000000000000124
46. Del Chirico F, Vernocchi P, Dallapiccola B, Putignani L. Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci (2014) 15:11678-99. doi:10.3390/ijms150711678
47. Cao AT, Yao S, Stefka AT, Liu Z, Qin H, Liu H, et al. TLR4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammation. J Leukoc Biol (2014) 96:895-905. doi:10.1189/jlb.3A0114-056RR
48. Weber A, Zimmermann C, Kieseier BC, Hartung HP, Hofstetter HH. Bacteria and their cell wall components uniformly co-active IL-17 producing thymocytes. Clin Exp Immunol (2014) 178:504-15. doi:10.1111/cei.12414
49. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin. Int Arch Allergy Immunol (2014) 164:171-7. doi:10.1159/000363502
50. Zeng H, Chi H. The interplay between regulatory T cells and metabolism in immune regulation. Oncoimmunology (2013) 2:e26586. doi:10.4161/onci.26586
51. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol (2012) 32:23-63. doi:10.1615/CritRevImmunol.v32.i1.30
52. Pereira S, Teixeira L, Aguilar E, Oliveira M, Savassi-Rocha A, Pelaez JN, et al. Modulation of adipose tissue inflammation by FOXP3+ Treg cell, IL-10, and TGF-β in metabolically healthy class III obese individuals. Nutrition (2014) 30:784-90. doi:10.1016/j.nut.2013.11.023
53. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes (2012) 7:284-94. doi:10.1111/j.2047-6310.2012.00064.x
54. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol (2008) 51:249-55. doi:10.1016/j.jacc.2007.10.016
55. Holt EM, Steffen LM, Moran A, Basu S, Steinberger J, Ross JA, et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc (2009) 109(3):414-21. doi:10.1016/j.jada.2008.11.036
56. Casas R, Sacanella E, Estruch R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr Metab Immune Disord Drug Targets (2014) 14:245-54. doi:10.2174/1871530314666140922153350
57. Bonaccio M, Di Castelnuovo A, Bonanni A, Costanzo S, De Lucia F, Persichillo M, et al. Decline of the Mediterranean diet at a time of economic crisis. Results from the Moli-Sani study. Nutr Metab Cardiovasc Dis (2014) 24:853-60. doi:10.1016/j.numecd.2014.02.014
58. Lim GB. Risk factors: mechanistic insights into the cardiovascular benefits of a Mediterranean diet. Nat Rev Cardiol (2014) 11:433. doi:10.1038/nrcardio.2014.92
59. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA (2004) 292:1433-9. doi:10.1001/jama.292.12.1433
60. Vieira VJ, Valentine RJ, Wilund KR, Antao N, Baynard T, Woods JA. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am J Physiol Endocrinol Metab (2009) 296:E1164-71. doi:10.1152/ajpendo.00054.2009
61. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol (2011) 11:607-11. doi:10.1038/nri3041
62. Miglio C, Peluso I, Raguzzini A, Villaño DV, Cesqui E, Catasta G, et al. Antioxidant and antiinflammatory response following high-fat meal consumption in overweight subjects. Eur J Nutr (2012) 52:1107-14. doi:10.1007/s00394-012-0420-7
63. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr (2011) 106:S5-78. doi:10.1017/S0007114511005460
64. Korhonen R, Kosonen O, Hamalainen M, Moilanen E. Nitric oxide-releasing compounds inhibit the production of interleukin-2,-4 and-10 in activated human lymphocytes. Basic Clin Pharmacol Toxicol (2008) 103:322-8. doi:10.1111/j.1742-7843.2008.00275.x
65. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 57:1470-81. doi:10.2337/db07-1403
66. Rigoulet M, Yoboue ED, Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal (2011) 14:459-68. doi:10.1089/ars.2010.3363
67. Leloup C, Casteilla L, Carrière A, Galinier A, Benani A, Carneiro L, et al. Balancing mitochondrial redox signaling: a key point in metabolic regulation. Antioxid Redox Signal (2011) 14:519-30. doi:10.1089/ars.2010.3424
68. Bisbal C, Lambert K, Avignon A. Antioxidants and glucose metabolism disorders. Curr Opin Clin Nutr Metab Care (2010) 13:439-46. doi:10.1097/MCO.0b013e32833a5559
69. Hulsmans M, Van Dooren E, Holvoet P. Mitochondrial reactive oxygen species and risk of atherosclerosis. Curr Atheroscler Rep (2012) 14:264-76. doi:10.1007/s11883-012-0237-0
70. Grimsrud PA, Picklo MJ, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics (2007) 6:624-37. doi:10.1074/mcp.M600120-MCP200
71. Atilgan D, Parlaktas BS, Uluocak N, Erdemir F, Kilic S, Erkorkmaz U, et al. Weight loss and melatonin reduce obesity-induced oxidative damage in rat testis. Adv Urol (2013) 2013:836121. doi:10.1155/2013/836121
72. Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 23:434-9. doi:10.1161/01.ATV.0000058402.34138.11
73. Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev (2000) 32:377-85. doi:10.1081/DMR-100102340
74. Daví G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA (2002) 288:2008-14. doi:10.1001/jama.288.16.2008
75. Lee H, Lee YJ, Choi H, Ko EH, Kim JW. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem (2009) 284:10601-9. doi:10.1074/jbc.M808742200
76. Fleming I, MacKenzie SJ, Vernon RG, Anderson NG, Houslay MD, Kilgour E. Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation. Biochem J (1998) 333:719-27.
77. Bansode RR, Huang W, Roy SK, Mehta M, Mehta KD. Protein kinase C deficiency increases fatty acid oxidation and reduces fat storage. J Biol Chem (2008) 283:231-6. doi:10.1074/jbc.M707268200
78. Huang W, Bansode R, Mehta M, Mehta KD. Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance. Hepatology (2009) 49:1525-36. doi:10.1002/hep.22815
79. Stowe DF, Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal (2009) 11:1373-414. doi:10.1089/ARS.2008.2331
80. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest (2009) 119:573-81. doi:10.1172/JCI37048
81. Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, et al. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med (2012) 18:1539-49. doi:10.1038/nm.2899
82. Loffredo L, Martino F, Carnevale R, Pignatelli P, Catasca E, Perri L, et al. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. J Pediatr (2012) 161:1004-9. doi:10.1016/j.jpeds.2012.05.042
83. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 114:1752-61. doi:10.1172/JCI21625
84. Bastard JP, Piéroni L, Hainque B. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev (2000) 16:192-201. doi:10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO;2-G
85. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 7:941-6. doi:10.1038/90984
86. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2002) 106:2767-70. doi:10.1161/01.CIR.0000042707.50032.19
87. Bonnefont-Rousselot D. Obesity and oxidative stress: potential roles of melatonin as antioxidant and metabolic regulator. Endocr Metab Immune Disord Drug Targets (2014) 14:159-68. doi:10.2174/1871530314666140604151452
88. Vazzana N, Guagnano MT, Cuccurullo C, Ferrante E, Lattanzio S, Liani R, et al. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J Clin Endocrinol Metab (2012) 97:E1726-30. doi:10.1210/jc.2012-1473
89. Vitale E, Jirillo E, Magrone T. Correlations between the youth healthy eating index, body mass index and the salivary nitric oxide concentration in overweight/obese children. Endocr Metab Immune Disord Drug Targets (2014) 14:93-101. doi:10.2174/1871530314666140307095630
90. Guenther PM, Reedy J, Krebs-Smith SM. Development of the healthy eating index 2005. J Am Diet Assoc (2008) 108:1896-901. doi:10.1016/j.jada.2008.08.016
91. Ruiz JR, Ortega FB, Martinez-Gomes D, Labayen I, Moreno LA, De Bourdeaudhuij I, et al. Objectively measured physical activity and sedentary time in European adolescents. Am J Epidemiol (2011) 174:173-84. doi:10.1093/aje/kwr068
92. Jimenez-Pavon D, Kelly J, Reilly JJ. Associations between objectively measured habitual physical activity and adiposity in children and adolescents: systematic review. Int J Pediatr Obes (2010) 5:3-18. doi:10.3109/17477160903067601
93. Ortega FB, Artero EG, Ruiz JR, Espana-Romero V, Jimenez-Pavon D, Vicente-Rodriguez G, et al. Physical fitness levels among European adolescents: the HELENA study. Br J Sports Med (2011) 45:20-9. doi:10.1136/bjsm.2009.062679
94. Herman KM, Sabiston CM, Mathieu ME, Tremblay A, Paradis G. Sedentary behavior in a cohort of 8-to 10-year-old children at elevated risk of obesity. Prev Med (2014) 60:115-20. doi:10.1016/j.ypmed.2013.12.029
95. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet (2011) 378:804-14. doi:10.1016/S0140-6736(11)60813-1
96. Collison KS, Zaidi MZ, Subhani SN, Al-Rubeaan K, Shoukri M, Al-Mohanna FA. Sugar-sweetened carbonated beverage consumption correlates with BMI, waist circumference, and poor dietary choices in school children. BMC Public Health (2010) 10:234. doi:10.1186/1471-2458-10-234
97. Choi JW. Enhanced nitric oxide production is closely associated with serum lipid concentrations in adolescents. Clin Chim Acta (2004) 347:151-6. doi:10.1016/j.cccn.2004.04.024
98. Ghasemi A, Zahediasl S, Azizi F. Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur J Epidemiol (2010) 25:45-53. doi:10.1007/s10654-009-9382-3
99. Codoñer-Franch P, Tavárez-Alonso S, Estal RM, Megías-Vericat J, Tortajada-Girbés M, Alonso-Iglesias E. Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. Atherosclerosis (2011) 215:475-80. doi:10.1016/j.atherosclerosis.2010.12.035
100. Ghasemi A, Zahediasl S, Azizi F. Elevated nitric oxide metabolites are associated with obesity in women. Arch Iran Med (2013) 16:521-5. doi:013169/AIM.008
101. Fogarty AW, Glancy C, Jones S, Lewis SA, McKeever TM, Britton JR. A prospective study of weight change and systemic inflammation over 9 y. Am J Clin Nutr (2008) 87:30-5.
102. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science (2011) 327:656-61. doi:10.1126/science.1178331
103. Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des (2008) 14:1225-30. doi:10.2174/138161208784246153
104. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol (2008) 80:1298-307. doi:10.1189/jlb.0406249
105. Gruber HJ, Mayer C, Mangge H, Fauler G, Grandits N, Wilders-Truschnig M. Obesity reduces the bioavailability of nitric oxide in juveniles. Int J Obes (2008) 32:826-31. doi:10.1038/sj.ijo.0803795
106. Jensen ME, Collins CE, Gibson PG, Wood LG. The obesity phenotype in children with asthma. Paediatr Respir Rev (2011) 12:152-9. doi:10.1016/j.prrv.2011.01.009
107. Lugogo NL, Kraft M, Dixon AE. Does obesity produce a distinct asthma phenotype? J App Physiol (1985) (2010) 108:729-34. doi:10.1152/japplphysiol.00845.2009
108. van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 63:570-4. doi:10.1111/j.1398-9995.2007.01597.x
109. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med (2006) 355:2226-35. doi:10.1056/NEJMra054308
110. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (1995) 269:546-9. doi:10.1126/science.7624778
111. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med (2012) 33:35-45. doi:10.1016/j.mam.2011.10.012
112. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation (2004) 109:2046-9. doi:10.1161/01.CIR.0000127953.98131.ED
113. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol (2005) 174:5789-95. doi:10.4049/jimmunol.174.9.5789
114. Stastny J, Bienertova-Vasku J, Vasku A. Visfatin and its role in obesity development. Diabetes Metab Syndr (2012) 6:120-4. doi:10.1016/j.dsx.2012.08.011
115. Hug C, Lodish HF. Medicine. Visfatin: a new adipokine. Science (2005) 307:366-7. doi:10.1126/science.1106933
116. Bidulescu A, Liu J, Hickson DA, Hairston KG, Fox ER, Arnett DK, et al. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study. BMC Cardiovasc Disord (2013) 13:9. doi:10.1186/1471-2261-13-9
117. Magrone T, Simone M, Mappa L, Tesse R, Giordano P, Altamura M, et al. Characterization of the immune inflammatory profile in obese asthmatic children. Endocr Metab Immune Disord Drug Targets (2014) 14:187-95. doi:10.2174/1871530314666140526095211
118. Pedersen SE, Hurd SS, Lemanske RF Jr., Becker A, Zar HJ, Sly PD, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol (2011) 46:1-17. doi:10.1002/ppul.21321
119. Youssef DM, Elbehidy RM, Shokry DM, Elbehidy EM. The influence of leptin on Th1/Th2 balance in obese children with asthma. J Bras Pneumol (2013) 39:562-8. doi:10.1590/S1806-37132013000500006
120. El-Wakkad A, Hassan Nel-M, Sibaii H, El-Zayat SR. Proinflammatory, anti-inflammatory cytokines and adipokines in students with central obesity. Cytokine (2013) 61:682-7. doi:10.1016/j.cyto.2012.11.010
121. Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota. Trends Immunol (2014) 35:507-17. doi:10.1016/j.it.2014.07.010
122. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 139:485-98. doi:10.1016/j.cell.2009.09.033
123. Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des (2013) 19:1329-42. doi:10.2174/138161213804805793
124. Mesquita DN, Barbieri MA, Goldani HA, Cardoso VC, Goldani MZ, Kac G, et al. Cesarean section is associated with increased peripheral and central adiposity in young adulthood: cohort study. PLoS One (2013) 8:e66827. doi:10.1371/journal.pone.0066827
125. Gibbs BG, Forste R. Socioeconomic status, infant feeding practices and early childhood obesity. Pediatr Obes (2014) 9:135-46. doi:10.1111/j.2047-6310.2013.00155.x
126. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 488:621-6. doi:10.1038/nature11400
127. Riley LW, Raphael E, Faerstein E. Obesity in the United States-dysbiosis from exposure to low-dose antibiotics? Front Public Health (2013) 1:69. doi:10.3389/fpubh.2013.00069
128. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science (2012) 336:1268-73. doi:10.1126/science.1223490
129. Spear BA, Barlow SE, Ervin C, Ludwig DS, Saelens BE, Schetzina KE, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics (2007) 120:S254-88. doi:10.1542/peds.2007-2329F
130. Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res (2001) 9:119-28. doi:10.1038/oby.2001.15
131. Davis MM, Gance-Cleveland B, Hassink S, Johnson R, Paradis G, Resnicow K. Recommendations for prevention of childhood obesity. Pediatrics (2007) 120:S229-53. doi:10.1542/peds.2007-2329E
132. Kar SS, Dube R, Kar SS. Childhood obesity-an insight into preventive strategies. Avicenna J Med (2014) 4:88-93. doi:10.4103/2231-0770.140653
133. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 58:1091-103. doi:10.1136/gut.2008.165886
134. Fan JG, Xu ZJ, Wang GL. Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model. World J Gastroenterol (2005) 11:5053-6. doi:10.3748/wjg.v11.i32.5053
135. Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, et al. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr (2012) 36:95S-105S. doi:10.1177/0148607111430087
136. Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effect of oligofructose on glucose and lipid metabolism in patients with nonalcoholic stateohepatitis: results of pilot study. Eur J Clin Nutr (2005) 59:723-6. doi:10.1038/sj.ejcn.1602127
137. Yang M, Gong S, Ye SQ, Lyman B, Geng L, Chen P, et al. Non-alcoholic Fatty liver disease in children: focus on nutritional interventions. Nutrients (2014) 6:4691-705. doi:10.3390/nu6114691
138. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol (2012) 7:91-109. doi:10.2217/fmb.11.142
139. Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr (2010) 104:83-92. doi:10.1017/S0007114510000176
140. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2011) 5:220-30. doi:10.1038/ismej.2010.118
141. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr (2010) 64:636-43. doi:10.1038/ejcn.2010.19
142. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep (2013) 15:337. doi:10.1007/s11894-013-0337-1
143. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 143:913-6.e7. doi:10.1053/j.gastro.2012.06.031
144. Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol (2012) 12:283. doi:10.1186/1471-2180-12-283
145. Karlsson CL, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) (2012) 20:2257-61. doi:10.1038/oby.2012.110
146. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA (2013) 110:9066-71. doi:10.1073/pnas.1219451110
147. Luoto R, Kalliomäki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) (2010) 34:1531-7. doi:10.1038/ijo.2010.50
148. Laitinen K, Poussa T, Isolauri E; Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr (2009) 101:1679-87. doi:10.1017/S0007114508111461
149. Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr (2010) 103:1792-9. doi:10.1017/S0007114509993898
150. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr (2012) 96:544-51. doi:10.3945/ajcn.112.037382
151. Jirillo E, Jirillo F, Magrone T. Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system. Int J Vitam Nutr Res (2012) 82:200-88. doi:10.1024/0300-9831/a000112
152. Kelishadi R, Farajian S, Safavi M, Mirlohi M, Hashemipour M. A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children. J Pediatr (Rio J) (2014) 90:161-8. doi:10.1016/j.jped.2013.07.003
153. Fekete K, Marosvölgyi T, Jakobik V, Decsi T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr (2009) 89:2070S-84S. doi:10.3945/ajcn.2009.27230I
154. Wang H, Storlien LH, Huang XF. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab (2002) 282:E1352-9. doi:10.1152/ajpendo.00230.2001
155. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med (2002) 113:63S-70S. doi:10.1016/S0002-9343(01)00994-9
156. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr (2007) 86:324-33.
157. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem (2010) 21:781-92. doi:10.1016/j.jnutbio.2009.12.004
158. Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res (2006) 45:203-36. doi:10.1016/j.plipres.2006.01.003
159. Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res (2003) 44:271-9. doi:10.1194/jlr.M200346-JLR200
160. Azain MJ. Role of fatty acids in adipocyte growth and development. J Anim Sci (2004) 82:916-24.
161. Madsen L, Petersen RK, Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim Biophys Acta (2005) 1740:266-86. doi:10.1016/j.bbadis.2005.03.001
162. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) (2009) 116:1-16. doi:10.1042/CS20070456
163. Hauner H, Brunner S, Amann-Gassner U. The role of dietary fatty acids for early human adipose tissue growth. Am J Clin Nutr (2013) 98:549S-55S. doi:10.3945/ajcn.112.040733
164. Mejía-Barradas CM, Del-Río-Navarro BE, Domínguez-López A, Campos-Rodríguez R, Martínez-Godínez MD, Rojas-Hernández S, et al. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents. Endocrine (2014) 45:98-105. doi:10.1007/s12020-013-9941-y
165. Magrone T, Kumazawa Y, Jirillo E. Polyphenol-mediated beneficial effects in healthy status and disease with special references to immune-based mechanisms. In: Watson R, Preedy V, Zibaldi S, editors. Polyphenols in Human Health and Disease. Vol. 1. Oxford: Elsevier (2014). p. 467-79.
166. Artero A, Artero A, Tarín JJ, Cano A. The impact of moderate wine consumption on health. Maturitas (2015) 80(1):3-13. doi:10.1016/j.maturitas.2014.09.007
167. Ferrières J. The French paradox: lessons for other countries. Heart (2004) 90:107-11. doi:10.1136/heart.90.1.107
168. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet (1992) 339:1523-6. doi:10.1016/0140-6736(92)91277-F
169. Franco JG, Lisboa PC, Lima NS, Amaral TA, Peixoto-Silva N, Resende AC, et al. Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning. J Nutr Biochem (2013) 24:960-6. doi:10.1016/j.jnutbio.2012.06.019
170. Park HS, Kim SH, Kim YS, Ryu SY, Hwang JT, Yang HJ, et al. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation. Biofactors (2009) 35:373-9. doi:10.1002/biof.38
171. Marzulli G, Magrone T, Vonghia L, Kaneko M, Takimoto H, Kumazawa Y. Immunomodulating and anti-allergic effects of Negroamaro and Koshu Vitis vinifera fermented grape marc (FGM). Curr Pharm Des (2014) 20:864-8. doi:10.2174/138161282006140220120640
172. Gu Y, Yu S, Lambert JD. Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. Eur J Nutr (2014) 53:149-58. doi:10.1007/s00394-013-0510-1
173. Moreno MF, De Laquila R, Okuda MH, Lira FS, de Souza GI, de Souza CT, et al. Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice. Diabetol Metab Syndr (2014) 6:84. doi:10.1186/1758-5996-6-84
174. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr (2014) 111:1263-71. doi:10.1017/S0007114513003784
175. Li G, Zhang Y, Mbuagbaw L, Holbrook A, Levine MA, Thabane L. Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review. BMJ Open (2014) 4:e004971. doi:10.1136/bmjopen-2014-004971
176. Di Renzo L, Rizzo M, Sarlo F, Colica C, Iacopino L, Domino E, et al. Effects of dark chocolate in a population of normal weight obese women: a pilot study. Eur Rev Med Pharmacol Sci (2013) 17:2257-66.
177. Riccioni G, Speranza L, Pesce M, Cusenza S, D'Orazio N, Glade MJ. Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition (2012) 28:605-10. doi:10.1016/j.nut.2011.11.028
178. Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, et al. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition (2010) 26:399-404. doi:10.1016/j.nut.2009.05.023
179. Korkmaz A, Manchester LC. Reactive nitrogen species; devastating intracellular players and melatonin as a defender. J Exp Integr Med (2011) 1:63-5. doi:10.5455/jeim.270311.ed.003
180. Deng WG, Tang ST, Tseng HP, Wu KK. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood (2006) 108:518-24. doi:10.1182/blood-2005-09-3691
181. Mauriz JL, Collado PS, Veneroso C, Reiter RJ, González-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J, Pineal Res (2013) 54:1-14. doi:10.1111/j.1600-079X.2012.01014.x
182. Srinivasan V, Ohta Y, Espino J, Pariente JA, Rodriguez AB, Mohamed M, et al. Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat Endocr Metab Immune Drug Discov (2013) 7:11-25. doi:10.2174/1872214811307010011
183. Jiménez-Aranda A, Fernández-Vázquez G, Campos D, Tassi M, Velasco-Perez L, Tan DX, et al. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res (2013) 55:416-23. doi:10.1111/jpi.12089
184. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev (2011) 12:167-88. doi:10.1111/j.1467-789X.2010.00756.x
185. Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S. Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol-and melatonin-induced cardioprotection. J Pineal Res (2011) 50:374-80. doi:10.1111/j.1600-079X.2010.00853.x
186. Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res (2011) 50:261-6. doi:10.1111/j.1600-079X.2010.00835.x
187. Reiter RJ, Tan DX, Korkmaz A, Ma S. Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med (2012) 44:564-77. doi:10.3109/07853890.2011.586365
188. Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: a review. J Pineal Res (2014) 56:371-81. doi:10.1111/jpi.12137
189. Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol (2010) 177:686-97. doi:10.2353/ajpath.2010.090998
190. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest (2005) 128:3792-8. doi:10.1378/chest.128.6.3792
191. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 124:e362-70. doi:10.1542/peds.2009-0051
192. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab (2004) 89:1196-9. doi:10.1210/jc.2003-031398
193. McLachlan CR, Poulton R, Car G, Cowan J, Filsell S, Greene JM, et al. Adiposity, asthma, and airway inflammation. J Allergy Clin Immunol (2007) 119:634-9. doi:10.1016/j.jaci.2006.10.029
194. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 104:S1-63. doi:10.1017/S0007114510003363
195. Hume ME. Historic perspective: prebiotics, probiotics, and other alternatives to antibiotics. Poult Sci (2011) 90:2663-9. doi:10.3382/ps.2010-01030
196. Magrone T, Perez de Heredia F, Jirillo E, Morabito G, Marcos A, Serafini M. Functional foods and nutraceuticals as therapeutic tools for the treatment of diet-related diseases. Can J Physiol Pharmacol (2013) 91:387-96. doi:10.1139/cjpp-2012-0307
197. Peluso I, Raguzzini A, Villano DV, Cesqui E, Toti E, Catasta G, et al. High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. Curr Pharm Des (2012) 18:85-90. doi:10.2174/138161212798919020
198. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science (2005) 308:1635-8. doi:10.1126/science.1110591
199. Califf K, Gonzalez A, Knight R, Caporaso JG. The human microbiome: getting personal. Microbe (2014) 9:410-5.
200. Casas R, Sacanella E, Urpí-Sardà M. The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One (2014) 9:e100084. doi:10.1371/journal.pone.0100084